• CLINAM 2018 with EUNCL Participation
    It was the 11th Summit of its kind. CLINAM again welcomed the participants from the community of nanomedicine, targeted drug delivery and precision medicine and bring together the pioneers and worldwide opinion leaders, not only to learn and discuss but also to develop new ideas, create new collaborative projects and shape the future of medicine.
  • Trainee position at JRC (5 months)
    The Consumer Products Safety Unit (F.2), part of Health, Consumers and Reference Materials Directorate-F at the JRC in Ispra (Italy), is looking for a trainee for the Nanobiotechnology laboratory.
  • The JRC is offering a position in the field of immunological safety testing of nanomaterials.
  • European Nanocharacterization laboratory (EUNCL) meets in Münster
    Three years ago, EUNCL was funded as starting community by the European H2020 program with the goal to increase the safety of new nano-based medical products. The representatives and experts from all over Europe met in Münster on May 24th to discuss about the progress in establishing the reference laboratory they set up for the last 3 years and its further development beyond 2019. The partners located in Münster are the only German party involved in EUNCL.
  • Seeking a Formulation Scientist
    The Nanotechnology Characterization Lab (NCL) provides nanotechnology formulation and characterization services for universities, the pharmaceutical industry and other government programs. Since our founding in 2004, the NCL has characterized more than 400 different nanomedicines for more than 100 organizations worldwide. We are currently seeking a Formulation Scientist to join our team. Those having experience with liposomes, micelles, and emulsions are especially encouraged to apply.
  • EURONANOFORUM 2017 – Partners presented EUNCL
    EUNCL partners presented the project and the service we offer to our sponsors in a booth as part of the exhibition. EuroNanoForum 2017 focused on how nano and materials technologies can strengthen competitiveness across all European industries.
  • EUNCL General Assembly
    The EUNCL Partners, Third Parties, Satellite Labs and External Advisory Board met for the second Annual Meeting of the EUNCL project. EUNCL partner TCD organized the meeting in Dublin, Ireland from 31 May – 2 June 2017.
  • BIOMS represented EUNCL at Labvolution 2017
    LABVOLUTION got off to a fine start and is on the right track for the future. That sums up the outcome of the European trade fair dedicated entirely to innovative lab equipment and lab workflow optimization.
  • EUNCL at CLINAM 2017
    It was the 10th Summit of its kind. The CLINAM Foundation used this Jubilee to present a programme with strong focus on the route of nanomedicine to successful clinical applications in targeted and precision medicine and related fields, to discuss critically common bottlenecks based on the 10-years’ experience of our broad international expert community.
    In the previous eight years, the CLINAM Summit grew to the largest in its field with 12 presenting Noble Laureates and more than 500 participants from academia, industry, regulatory authorities and policy from over 40 countries in Europe and worldwide.
  • Nanotechnology: a key to the future of medicine
    Interview with Dr. Klaus-Michael Weltring, Managing Director, Nanobioanalytics Center Münster, Spokesperson of the German NanoBioMedicine Platform
  • European Nanomedicine Characterisation Laboratory (EUNCL)
    Open Call for Proposals – Continous Application
  • General Assembly 2016 in Trondheim
    Looking back at a successful first project year
  • European Nanotechnology Experts Visit NCL; Harmonize Best Practices for Nanomedicine Collaboration in Europe
    European nanotechnology experts studied best practices and methods at the Nanotechnology Characterization Laboratory (NCL), and shared their own knowledge with NCL scientists before heading home to kick-start an NCL-like operation in Europe.
  • EUNCL present at EU-US workshop on H2020
    A delegation from EUNCL has been invited to attend an EU-US workshop on H2020, the European Union's main instrument for funding research and innovation activities from 2014 to 2020. Horizon 2020 focuses on three overarching priorities – excellent science, industrial leadership and societal challenges and is open to participants from anywhere in the world.
  • Cancer in the crosshairs
    Switzerland has joined an unprecedented scientific collaboration between Europe and the United States to accelerate nanomedicine testing in a bid to conquer a common enemy: cancer.
  • EUNCL Kick-off
    Leti Announces Launch of First European Nanomedicine Characterisation Laboratory
News 1 to 17 of 17 | Page 1 of 1

Events where you meet EUNCL

More Events ...

European Nanomedicine Characterisation Laboratory (EUNCL)

Call for Proposals!


More News ...